Lifecare ASA
Developing implantable CGM nanosensors for human & veterinary diabetes management.
LIFE | OL
Overview
Corporate Details
- ISIN(s):
- NO0013250563 (+2 more)
- LEI:
- 254900D88MYGZ7JD5P39
- Country:
- Norway
- Address:
- Ytrebygdsvegen 215, 5158 Bergen
- Website:
- https://lifecare.no/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Lifecare ASA is a clinical-stage medical sensor company developing proprietary nanotechnology for medical monitoring. Its core Sencell technology utilizes osmotic pressure to enable miniaturized, implantable nanobiosensors that can measure various body analytes. The company's primary focus is on diabetes management, with the goal of creating a next-generation Continuous Glucose Monitoring (CGM) system that is painless, accurate, and offers long-term use for both human and veterinary patients. Lifecare is advancing its technology through clinical development and process automation to achieve regulatory approval and commercialization. The company also licenses its technology platform for broader medical and lifestyle applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-26 18:40 |
Director's Dealing
Lifecare ASA: Mandatory notification of trade - Attachment: PDMR Attachment.pdf
|
English | 131.6 KB | ||
| 2025-09-26 18:40 |
Director's Dealing
Lifecare ASA: Mandatory notification of trade - Attachment: Lifecare ASA- Manda…
|
English | 59.6 KB | ||
| 2025-09-26 18:40 |
Director's Dealing
Lifecare ASA: Mandatory notification of trade
|
English | 1.1 KB | ||
| 2025-09-24 07:00 |
Regulatory News Service
Lifecare strengthens miniaturisation roadmap with new patent applications - Att…
|
English | 55.4 KB | ||
| 2025-09-24 07:00 |
Regulatory News Service
Lifecare strengthens miniaturisation roadmap with new patent applications
|
English | 2.5 KB | ||
| 2025-09-15 07:00 |
Regulatory News Service
LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY - Attachment: …
|
English | 56.1 KB | ||
| 2025-09-15 07:00 |
Regulatory News Service
LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY
|
English | 2.9 KB | ||
| 2025-08-27 07:00 |
Regulatory News Service
Reconfirmed positive results in veterinary study support path toward market ent…
|
English | 64.0 KB | ||
| 2025-08-27 07:00 |
Regulatory News Service
Reconfirmed positive results in veterinary study support path toward market ent…
|
English | 4.6 KB | ||
| 2025-08-20 07:00 |
Investor Presentation
LIFE: Lifecare ASA Q2 2025 results - Attachment: Lifecare Q2 2025 Presentation.…
|
English | 2.5 MB | ||
| 2025-08-20 07:00 |
Quarterly Report
LIFE: Lifecare ASA Q2 2025 results - Attachment: Lifecare Q2 2025 Report.pdf
|
English | 742.4 KB | ||
| 2025-08-20 07:00 |
Earnings Release
LIFE: Lifecare ASA Q2 2025 results
|
English | 4.1 KB | ||
| 2025-08-13 07:47 |
Regulatory News Service
Lifecare advances CE mark preparation for its groundbreaking medical device - A…
|
English | 57.3 KB | ||
| 2025-08-13 07:47 |
Regulatory News Service
Lifecare advances CE mark preparation for its groundbreaking medical device
|
English | 4.1 KB | ||
| 2025-08-12 14:35 |
Report Publication Announcement
Lifecare ASA (LIFE): Invitation to presentation of Q2 2025 results 20 August at…
|
English | 60.8 KB |
Automate Your Workflow. Get a real-time feed of all Lifecare ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Lifecare ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
